The National Institute of Health Research (NIHR) is a major funder of these projects. This funding come through the funding streams managed by NIHR Central Commissioning Facility:
- Programme Grants for Applied Research (PGfAR)
- Programme Development Grants (PDG)
- Research for Patient Benefit (RfPB)
- Invention for Innovation (i4i)
NIHR funding is also provided by streams managed by the NIHR Evaluation, Trials and Studies Coordinating Centre (NETSCC):
- Efficacy, Mechanism and Evaluation (EME)
- Health Technology Assessment (HTA)
- Public Health Research (PHR)
- Health Services and Delivery Research (HS&DR)
Other sources of project funding include:
- Arthritis Research UK
- British Heart Foundation
- Cancer Research UK
- Diabetes Research UK
- Medical Research Council and
- the US-based National Institutes of Health (NIH-NINDS).
Industry funding includes Novartis, Roche and Bristol-Myers-Squibb.
As a UKCRC registered CTU based in England, and with a strong track record in winning funding from the NIHR funding streams managed through NETSCC, NCTU is in receipt of NIHR Clinical Trials Unit Support Funding, which provides pump-priming resources.